HER-2 testing in breast cancer -: Reply

被引：0
|
作者：
Yaziji, H [1 ]
Barry, TS
Gown, AM
机构：
[1] Baptist Hosp Miami, Dept Pathol, Miami, FL 33176 USA
[2] PhenoPath Labs, Seattle, WA USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2004年 / 292卷 / 15期
关键词：
D O I：
10.1001/jama.292.15.1818-a
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1818 / 1818
页数：1
相关论文
共 50 条
  • [41] HER-2 and choice of adjuvant chemotherapy in breast cancer
    Paik, S
    Park, C
    SEMINARS IN ONCOLOGY, 2001, 28 (04) : 332 - 335
  • [42] Her-2/neu oncogen amplification in breast cancer
    Canepa, Mariana
    Deninghoff, Valeria
    Perazzo, Florencia
    Paesani, Fernando
    Nieto, Silvana
    Garcia, Alejandro
    Avagnina, Alejandra
    Elsner, Boris
    MEDICINA-BUENOS AIRES, 2012, 72 (01) : 88 - 89
  • [43] Her-2 predicts survival of breast cancer patients
    不详
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (08) : 1160 - 1160
  • [44] HER-2/neu as a predictive marker in breast cancer
    Konecny, G
    Pegram, M
    Untch, M
    Thomssen, C
    Jänicke, F
    Hepp, H
    Slamon, DJ
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2000, 60 (12) : 609 - 619
  • [45] Immunological Landscape of HER-2 Positive Breast Cancer
    Moragon, Santiago
    Hernando, Cristina
    Martinez-Martinez, Maria Teresa
    Tapia, Marta
    Ortega-Morillo, Belen
    Lluch, Ana
    Bermejo, Begona
    Cejalvo, Juan Miguel
    CANCERS, 2022, 14 (13)
  • [46] Her-2/neu and Topoisomerase iiα in Breast Cancer
    Tero A.H. Järvinen
    Edison T. Liu
    Breast Cancer Research and Treatment, 2003, 78 : 299 - 311
  • [47] The influence of serum HER-2 levels and HER-2 codon 655 polymorphism on breast cancer outcome
    Papadopoulou, E.
    Tripsianis, G.
    Anagnostopoulos, K.
    Tentes, I.
    Kakolyris, S.
    Galazios, G.
    Sivridis, E.
    Simopoulos, K.
    Kortsaris, A.
    NEOPLASMA, 2008, 55 (02) : 113 - 121
  • [48] erbB-2 (HER-2) and breast cancer progression
    Edgerton, SM
    Moore, D
    Merkel, D
    Thor, AD
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2003, 11 (03) : 214 - 221
  • [49] HER-2 testing and trastuzurnab therapy for metastatic breast cancer: A cost-effectiveness analysis
    Elkin, EB
    Weinstein, KC
    Winer, EP
    Kuntz, KM
    Schnitt, SJ
    Weeks, JC
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) : 854 - 863
  • [50] The feasibility of Her-2 testing in metastatic breast cancer specimens obtained by needle biopsy.
    Bui, M
    Loya, A
    Masood, S
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S66 - S66
12345